It targets melanin synthesis without significantly affecting melanocyte cells themselves meaning it's working on the pigment-production pathway, not causing cell damage
The 2024 safety alert In mid-2024, the FDA warned that it had received reports of people overdosing on compounded semaglutide by injecting up to 20 times their intended dose
Generally, alveolar macrophage inflammation and epithelial cell damage are the triggering events of pulmonary fibrosis, followed by fibroblast proliferation and myofibroblast activation in response to cytokines, which in turn results in excessive extracellular matrix (ECM) deposition [2, 3]
Clinical pharmacogenetics implementation consortium guideline for CYP2D6, OPRM1, and COMT genotypes and select opioid therapy
Category 2 Placement: The FDA placed BPC-157 in Category 2 of the 503A bulk drug substances list, citing "significant safety concerns." This effectively blocked compounding pharmacies from preparing BPC-157 formulations for patients